^
BIOMARKER:

KRAS exon 2 mutation

i
Other names: KRAS, KRAS1, KRAS2, Kirsten rat sarcoma viral oncogene homolog
Entrez ID:
Related biomarkers:
KRAS exon 2 mutation
CRC
bevacizumab
Sensitive: C2 – Inclusion Criteria
KRAS exon 2 mutation
Pancreatic Cancer
erlotinib
Resistant: C3 – Early Trials
KRAS exon 2 mutation
CRC
panitumumab
Resistant: C3 – Early Trials
KRAS exon 2 mutation
NSCLC
gefitinib
Resistant: C3 – Early Trials
KRAS exon 2 mutation
CRC
cetuximab
Resistant: C3 – Early Trials
KRAS exon 2 mutation
CRC
selumetinib
Sensitive: C3 – Early Trials
KRAS exon 2 mutation
NSCLC
erlotinib
Resistant: C3 – Early Trials